KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Receivables (2016 - 2026)

Thermo Fisher Scientific filings provide 18 years of Receivables readings, the most recent being $10.9 billion for Q1 2026.

  • On a quarterly basis, Receivables rose 10.86% to $10.9 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $10.9 billion, a 10.86% increase, with the full-year FY2025 number at $10.6 billion, up 9.77% from a year prior.
  • Receivables hit $10.9 billion in Q1 2026 for Thermo Fisher Scientific, up from $10.6 billion in the prior quarter.
  • In the past five years, Receivables ranged from a high of $10.9 billion in Q1 2026 to a low of $8.9 billion in Q3 2022.
  • Median Receivables over the past 5 years was $9.6 billion (2024), compared with a mean of $9.7 billion.
  • Biggest five-year swings in Receivables: soared 41.59% in 2022 and later fell 0.59% in 2024.
  • Thermo Fisher Scientific's Receivables stood at $9.4 billion in 2022, then increased by 2.51% to $9.7 billion in 2023, then fell by 0.39% to $9.6 billion in 2024, then grew by 9.77% to $10.6 billion in 2025, then grew by 3.05% to $10.9 billion in 2026.
  • The last three reported values for Receivables were $10.9 billion (Q1 2026), $10.6 billion (Q4 2025), and $10.5 billion (Q3 2025) per Business Quant data.